scispace - formally typeset
Search or ask a question

Answers from top 10 papers

More filters
Papers (10)Insight
This increased availability of endocannabinoids might stimulate cannabinoid receptors in a pathophysiological manner.
However, new data, presented by Tam and colleagues in this issue of the JCI, demonstrate that selective blockade of peripheral cannabinoid receptors may be a novel successful therapeutic approach.
The results indicate that modulating cannabinoid receptors represent a valuable approach for the treatment of neuropathic pain.
Open accessJournal ArticleDOI
J M Walker, N M Strangman, Susan M. Huang 
46 Citations
These observations and others thus suggest that a natural function of cannabinoid receptors and their endogenous ligands is to regulate pain sensitivity.
These data demonstrate that neurite remodeling is a newly discovered function of CB1 cannabinoid receptors.
In particular, emerging evidence suggests that agonists of cannabinoid receptors expressed by tumor cells may offer a novel strategy to treat cancer.
However, emerging evidences suggest the role of cannabinoid receptors (CBRs) in curtailing the progression of PD by activating neuroprotective pathways.
Targeting the cannabinoid receptors has the potential to treat a variety of conditions such as pain, neurodegeneration, appetite, immune function, anxiety, cancer, and others.
Cannabinoid receptors thus have the potential to prevent other Gi/o-coupled receptors from transducing their biological signals.
Our results provide further evidence that activation of peripheral cannabinoid receptors may be a useful target for the treatment of cancer pain.

See what other people are reading

How cytokines levels change with the age?
5 answers
Cannabinoid receptor-G protein interactions: Gαi1-bound structures of IC3 and a mutant with altered G protein specificity
5 answers
Are cannabinoid used to treat rosacea, atopic dermatitis and psoriasis?
5 answers
How have researchers studied the impact of enrichment on rabbit behavior in relation to sexual dimorphism?
10 answers
What ist an optimal in vitro Media for cannabis?
4 answers
Is wnt7b an oncogene in cancer?
4 answers
How can hemp help humanity?
5 answers
Hemp, a versatile plant with a long history of human use, offers numerous benefits to humanity. It can provide essential nutrients like polyunsaturated fatty acids, complete proteins, and micronutrients, potentially aiding in combating diet-related diseases. Additionally, hemp shows promise in the medical field, with cannabinoids like cannabidiol (CBD) demonstrating anti-cancer properties and anti-inflammatory effects. Furthermore, hemp protein products have been found to possess antioxidant and anti-inflammatory properties, suggesting a potential role in improving chronic inflammatory conditions and promoting regenerative processes. Beyond nutrition and medicine, hemp's fast growth, high biomass production, and adaptability make it a valuable resource for various commercial products like textiles, paper, biofuels, and construction materials, offering sustainable solutions for environmental conservation and remediation of polluted soils.
Crosstalk CB1 and CB2 receptors in regulating appetite?
5 answers
The crosstalk between cannabinoid receptors CB1 and CB2 plays a crucial role in regulating appetite. While CB1 receptors are primarily involved in modulating food intake and energy balance, CB2 receptors also contribute to the regulation of appetite. Studies suggest that the activation of CB1 receptors can increase appetite and stimulate feeding, whereas blocking CB1 receptors suppresses hunger and induces hypophagia. Additionally, the interaction between CB1 receptors and other neurotransmitter systems, such as the hypocretinergic system, further influences appetite regulation. Understanding the intricate interplay between CB1 and CB2 receptors provides insights into potential therapeutic targets for managing appetite and addressing conditions like obesity and metabolic disorders.
What is the role of Crosstalk CB1 and CB2 receptors in regulating appetite?
4 answers
Crosstalk between CB1 and CB2 receptors plays a crucial role in regulating appetite. Activation of CB1 receptors promotes appetite and stimulates feeding, while CB1 blockade suppresses hunger and induces hypophagia. The peripheral CB1 receptor activation impacts energy balance by inhibiting satiety, increasing food intake, altering taste sensation, and promoting energy storage. Additionally, CB1 receptors modulate food intake by interacting with classical neurotransmitters in neural networks controlling energy metabolism and feeding behavior. The endocannabinoid system, including CB1 receptors, influences feeding behaviors through partial agonism by Δ9-THC, inducing a preference for palatability. Understanding the intricate interplay between CB1 and CB2 receptors provides insights into potential therapeutic targets for managing appetite and body weight.
What are yields of Bulel and Aucan Tritordeum?
5 answers
The yield of 'Bulel' Tritordeum variety was observed to be 4753.5 kg ha-1 in response to fertilization in a field experiment in Greece. Additionally, Tritordeum, as a new cereal crop, has shown yields close to those of commercial wheats after only 12 years of breeding, indicating its potential as a viable crop option. On the other hand, the yield data for Aucan Tritordeum is not explicitly provided in the given contexts. However, the success of Tritordeum as a crop, in general, highlights its promising agronomic performance and potential as a genetic bridge for wheat breeding, showcasing its significance as a new and innovative crop. Further research and breeding efforts are ongoing to enhance the agronomic characteristics of Tritordeum varieties, indicating a positive trajectory for their future yields.
Is there an association between lowered serotonin concentrations or activity and depression?
5 answers
There is no consistent evidence linking lowered serotonin concentrations or activity to depression, as suggested by various studies. The serotonin hypothesis of depression, which posits a direct association between serotonin levels and depressive symptoms, has been extensively scrutinized. Research indicates that depression may not be caused by decreased serotonin activity, with some studies even suggesting that long-term antidepressant use could reduce serotonin concentration. Additionally, investigations into the effects of specific genetic variations related to the serotonergic and endocannabinoid systems have shown potential susceptibility to depression in carriers of certain alleles. Overall, the current body of evidence does not strongly support the notion that lowered serotonin concentrations or activity are directly linked to the development of depression.